P275 Platinum compounds (PLcs) added to standard adjuvant or neoadjuvant regimen of doxorubicin plus cyclophosphamide (AC), followed by weekly paclitaxel (wP) in triple negative (TN), HER 2-neu positive (HER 2+) or locally advanced breast cancer (LABC)

✍ Scribed by M. Vassilaki; A. Sioulas; M. Tsantekidou; A. Klitsa; N. Desses; C. Georgakopoulos; C. Kosmidis; C. Tsionou; V. Parassiris; G. Xepapadakis

• Book ID: 114316614
• Publisher: Elsevier Science
• Year: 2011
• Tongue: English
• Weight: 39 KB
• Volume: 20
• Category: Article
• ISSN: 0960-9776
• DOI: 10.1016/s0960-9776(11)70217-x